In a 40‑year‑old man weighing 73 kg with type 1 diabetes, creatinine 1.24 mg/dL, eGFR 75 mL/min, currently on insulin glargine (Lantus) 14 U daily and fixed bolus doses of insulin aspart (Novolog) 18 U at breakfast, 14 U at lunch, and 10 U at dinner, who received dexamethasone 6 mg 24 hours ago and is now started on continuous insulin infusion (CII), what should his insulin glargine (Lantus) dose, insulin‑sensitivity factor (ISF), and insulin‑to‑carbohydrate ratio (ICR) be?

Insulin Dosing After Dexamethasone and Insulin Infusion

For this 40-year-old with type 1 diabetes, reduced GFR (75 mL/min), and recent dexamethasone exposure requiring insulin infusion totaling approximately 70 units over 24 hours, initiate Lantus at 25-28 units daily (approximately 80% of the 35-unit total from infusion), use an insulin-resistant correction scale (ISF 1:30-40), and calculate ICR at 1:10-12 given the steroid-induced insulin resistance.1, 2

Calculating Total Daily Dose (TDD)

Step 1: Assess Insulin Requirements from Infusion

• Your patient received approximately 70 units over the past 24 hours on insulin drip
• This represents actual insulin needs during dexamethasone-induced hyperglycemia
• Use 80% of infusion total as starting subcutaneous TDD = 56 units 1

Step 2: Adjust for Patient-Specific Factors

Critical consideration: This patient has reduced renal function (GFR 75 mL/min)

• The Endocrine Society guidelines recommend 0.2-0.3 U/kg for GFR <60 mL/min 1
• While this patient is at 75 mL/min (just above threshold), insulin glargine clearance is affected even at this level 3
• Weight-based calculation: 73 kg × 0.4 U/kg = 29 units (using 0.4 rather than 0.5 due to borderline renal function)

Dexamethasone effect:

• Recent study showed insulin glargine is commonly underdosed for dexamethasone-induced hyperglycemia 4
• Patients on corticosteroids should use the insulin-resistant correction column 1
• Dexamethasone causes predominantly afternoon/evening hyperglycemia 2

Step 3: Final TDD Calculation

Recommended TDD: 35-40 units (splitting the difference between infusion-based 56 units × 0.5 = 28 units and weight-based 29 units, adjusted upward for steroid effect)

Basal Insulin (Lantus) Dosing

Lantus dose: 25-28 units once daily in the morning 1, 2

Rationale:

• 50% of TDD as basal = 17.5-20 units from standard calculation 1
• However, increase to 60-70% of TDD (25-28 units) for dexamethasone 2
• Morning dosing is preferred for steroid-induced hyperglycemia to match the afternoon/evening hyperglycemia pattern 2
• This is higher than his home dose of 14 units, appropriate given recent insulin requirements

Important Caveat:

Monitor closely for hypoglycemia as dexamethasone effect wanes - insulin requirements can decline rapidly after steroids are discontinued, requiring dose reduction 2. With GFR 75, insulin glargine clearance is already somewhat impaired 3.

Prandial Insulin Dosing

Total prandial insulin: 10-12 units daily (remaining 30% of TDD)

• Distribute as: 4 units breakfast, 4 units lunch, 4 units dinner 1

This is substantially lower than his home doses (18/14/10 units), but appropriate because:

• He's transitioning from infusion where correction doses handled most needs
• Need to avoid stacking insulin with new regimen
• Can titrate upward based on response

Insulin Sensitivity Factor (ISF)

Use ISF of 1:30-40 (1 unit lowers glucose by 30-40 mg/dL)

Calculation:

• 1800 rule: 1800 ÷ TDD = 1800 ÷ 40 = 45
• Adjust to 1:30-40 for steroid resistance 1
• Use the insulin-resistant correction scale from Endocrine Society guidelines 1:
  • 141-180 mg/dL: 6 units
  • 181-220 mg/dL: 8 units
  • 221-260 mg/dL: 10 units
  • 261-300 mg/dL: 12 units
  • 301-350 mg/dL: 14 units
  • 351-400 mg/dL: 16 units
  • ≥400 mg/dL: 18 units

Critical: Switch to "usual" or "sensitive" column once dexamethasone effect resolves (typically 24-48 hours after last dose) 1, 2

Insulin-to-Carbohydrate Ratio (ICR)

Use ICR of 1:10-12 (1 unit per 10-12 grams carbohydrate)

Calculation:

• 500 rule: 500 ÷ TDD = 500 ÷ 40 = 12.5
• Round to 1:10-12 for steroid-induced resistance 1
• This is more aggressive than his typical ratio would be (likely 1:15-20 at home given his doses)

Once dexamethasone effect resolves, recalculate to approximately 1:15 (500 ÷ 35 = 14)

Monitoring and Titration Algorithm

Days 1-3:

• Check glucose before meals and bedtime (minimum 4 times daily)
• If fasting glucose >150 mg/dL on 2 consecutive days: increase Lantus by 2-4 units 1, 5
• If fasting glucose <80 mg/dL: decrease Lantus by 10-20% 1, 5

Days 4-7:

• Reassess TDD based on total correction insulin used
• If requiring >10 units correction daily, increase scheduled doses by that amount distributed 50% basal/50% prandial 1
• Watch for rapid decline in insulin needs as steroid effect wanes 2

Special Considerations for Renal Impairment:

• More frequent glucose monitoring - at least 4-6 times daily initially 1, 6
• Lower threshold for dose reduction - reduce by 20% (not 10%) if any hypoglycemia without clear cause 1
• Insulin glargine shows 27-30% dose reduction at GFR <60 compared to GFR >90 3
• This patient at GFR 75 is in transition zone - expect 10-15% reduced clearance

Common Pitfalls to Avoid

1. Underdosing basal insulin for steroid effect - most protocols underdose insulin glargine for dexamethasone, leading to persistent hyperglycemia requiring excessive correction doses 4

2. Continuing high doses after steroid discontinuation - insulin requirements drop rapidly, often within 24-48 hours 2

3. Using evening Lantus dosing - morning dosing better matches dexamethasone's afternoon/evening hyperglycemia pattern 2

4. Ignoring renal function - even mild renal impairment (GFR 60-90) affects insulin glargine clearance 3, 7

5. Relying solely on correction insulin - the infusion data shows this patient needed scheduled insulin, not just reactive dosing 1